# Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients

Study · id `cardio:ct-nct01819441` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01819441](<https://clinicaltrials.gov/study/NCT01819441>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT01819441

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1200 participants.

## Technical summary

Registry record NCT01819441. Randomized; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1200 participants (planned count; ClinicalTrials.gov record NCT01819441, source copy `cardio:ctgov-nct01819441-2015-10-23`, retrieved 2026-11-18)
- Start date: 2012-05 (registry gives no type) (ClinicalTrials.gov record NCT01819441, source copy `cardio:ctgov-nct01819441-2015-10-23`, retrieved 2026-11-18)
- Primary completion: 2016-12 (anticipated) (ClinicalTrials.gov record NCT01819441, source copy `cardio:ctgov-nct01819441-2015-10-23`, retrieved 2026-11-18)
- Completion: 2016-12 (anticipated) (ClinicalTrials.gov record NCT01819441, source copy `cardio:ctgov-nct01819441-2015-10-23`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT01819441, source copy `cardio:ctgov-nct01819441-2015-10-23`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01819441-2015-10-23`, retrieved 2026-11-18)

## The registry's words

- Brief title: Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients
- Acronym: APPROVE
- Condition: Cerebral Small Vessel Diseases
- Intervention (Drug): Azelnidipine
- Intervention (Drug): Perindopril
- Intervention (Drug): hydrochlorothiazide
- Lead sponsor: Yining Huang
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Cerebral small vessel disease (`cardio:cerebral-small-vessel-disease`)
- Registry intervention name matches this record: Hydrochlorothiazide (`cardio:hydrochlorothiazide`)

## Provenance

Content hash: 945827127f7d8951a1a04d563cc0b4451480573b8b68c47d32586fd9ff19d130
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
